Navigation Links
Susan G. Komen For The Cure, Karmanos Cancer Institute, Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality
Date:10/23/2007

ree times more likely to die from the disease. African- American women in Michigan are dying of breast cancer at a higher rate (34 per 100,000) than White women (23 per 100,000). A study commissioned by Komen for the Cure highlighted Wayne County among eight communities in the U. S. with an alarmingly high breast cancer mortality rate (29.7 vs. 26.0 for U.S.).

"The most significant risk factors for getting breast cancer are being female and getting older. We need more breast care navigators who can help women make sense of the health care system. We need more funding for cancer research. Most of all, we need to move beyond talk and into action," said Kimberly Simpson, chief operating officer for Susan G. Komen for the Cure.

The forum was moderated by Rene Syler, author and former CBS Early Show anchor whose family history of breast cancer and diagnosis of a pre-cancerous condition motivated her undergo a prophylactic mastectomy earlier this year. Syler moderated a panel of leading physicians and executives from the Barbara Ann Karmanos Cancer Institute, The Detroit Medical Center, Oakwood Hospital, St. John Heath System and Henry Ford Hospital who talked about what their institutions are doing -- and what more must be done -- to address Wayne County's high breast cancer mortality rate and the disparities that cause some women to die of breast cancer more than others.

Crystal Greene from Ford Motor Company and 29-year-old breast cancer survivor Nikia Hammonds Blakely spoke about a new Komen initiative called Circle of Promise. Circle of Promise is designed to engage African American women in the fight to end breast cancer by fostering increased awareness, support, empowerment and action. The heart and soul of the campaign is its online community, http://www.komen.org/circle. Breast cancer survivor and Detroit Chief of Police Ella Bully-Cummings urged all women of metro Detroit to get screened.<
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Vitamin B12 can help in detecting cancers
6. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
7. Consensus on "Combination Therapy" for Breast Cancer
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
10. The Cancer Rumour mill working over time
11. Want skin cancer? Please have a cigarette
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Westaim announces 2008 year-end results 2Health News:Westaim announces 2008 year-end results 3Health News:Westaim announces 2008 year-end results 4Health News:Westaim announces 2008 year-end results 5Health News:Westaim announces 2008 year-end results 6Health News:Westaim announces 2008 year-end results 7Health News:Westaim announces 2008 year-end results 8Health News:Westaim announces 2008 year-end results 9Health News:Westaim announces 2008 year-end results 10Health News:Westaim announces 2008 year-end results 11Health News:Westaim announces 2008 year-end results 12Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 2Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 3Health News:Working With Robots May Help After a Stroke 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 3Health News:Dentists Often First to Spot Eating Disorders in Patients 2Health News:Dentists Often First to Spot Eating Disorders in Patients 3
Breaking Medicine Technology:Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Navigating in the ocean of molecules 9514 1Navigating in the ocean of molecules 9514 2Navigating in the ocean of molecules 9514 3NIH stimulus funding supports Emory biomedical scientists 9512 1NIH stimulus funding supports Emory biomedical scientists 9512 2NIH stimulus funding supports Emory biomedical scientists 9512 3NIH stimulus funding supports Emory biomedical scientists 9512 4Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 1Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 2Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 3
Other Medicine Technology:Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 2Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 3Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7